Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon
about
Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profilePersistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission.Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-α monotherapy.Phenotypic and functional characterization of the host immune compartment of chronic myeloid leukaemia patients in complete haematological remission.Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia
P2860
Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon
description
article
@en
im Februar 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 1998
@uk
name
Evidence for specific immune r ...... tients treated with interferon
@en
Evidence for specific immune r ...... tients treated with interferon
@nl
type
label
Evidence for specific immune r ...... tients treated with interferon
@en
Evidence for specific immune r ...... tients treated with interferon
@nl
prefLabel
Evidence for specific immune r ...... tients treated with interferon
@en
Evidence for specific immune r ...... tients treated with interferon
@nl
P2093
P356
P1433
P1476
Evidence for specific immune r ...... tients treated with interferon
@en
P2093
P2888
P304
P356
10.1038/SJ.LEU.2400919
P50
P577
1998-02-01T00:00:00Z
P6179
1050355725